Please login to the form below

Not currently logged in
Email:
Password:

Bayer finances sustainable development chair at Chinese university

Bayer says it will finance a chair in sustainable development at Tongji University in China

German-based pharmaceutical company Bayer has said it will finance a chair in sustainable development at Tongji University in China.

The chair is a joint project with Tongji University and the UN Environment Programme (UNEP). Bayer will support the new chair, student scholarships and research activities for an initial period of five years with a sponsorship of USD 1m.

The Bayer-Tongji Chair for Sustainable Development will focus on advanced education and research into emerging environmental technologies. It will also support sustainable development projects which enhance China's solutions to environmental, economic and social sustainability problems.

Member of Bayer's management board, Wolfgang Plischke, said: "The path China takes to achieve sustainable growth and protect its environment will have far-reaching effects. We know the government is committed to meeting the challenges, and Bayer is here to help."

Zhao Jianfu, vice-president of Tongji University, added: "The University considers environmental protection and sustainable development one of its top priorities. We are delighted to be working closely with Bayer, a company known worldwide for its outstanding achievements in the area of sustainability."

China plans to reduce its energy consumption and emissions by 20 and 10 per cent, respectively, between 2006 and 2010. To achieve this, the country says it needs help for funding and technologies.

Bayer already provided new technologies and specialised services for China in wastewater treatment, environmental protection and conversion of biological energy sources, added Plischke.

30th September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics